Company logo
Get Listed

Refractory Multiple Myeloma- New FDA Approved Treatment 2022

Discover insights into refractory multiple myeloma. Explore treatment options, clinical trials, and expert care for managing this challenging condition.

  • Cancer
  • Blood Cancer Treatment

By Ipshita Ghoshal

7th Dec '22

Blog Banner Image

Multiple myeloma is one of the rarest cancers which grows in plasma cells in blood. In 2022, an estimated 34,470 cases of multiple myeloma were recorded in the United States. The death toll went up to 12,640 in the United States. Only 55% of people can survive up to 5 years after a cancer diagnosis. Most people struggle to live that long after being diagnosed with multiple myeloma.

According to the International Myeloma Foundation, relapses of multiple myeloma are common. The majority of patients experience remissions and relapses numerous times over the course of their illness.

The initial remission stage may last two to three years or longer for those with no additional risk factors.

According to a study in 2016, relapse rates in 511 patients with multiple myeloma after therapy from 2006 to 2014 were examined.

16 percent of the individuals had an early relapse within a year. But 84% either experienced a relapse within a year or had none at the time of the follow-up.

Researchers keep on studying the disease to develop various refractory multiple myeloma treatments to increase the relative survival rate of patients.

Also in India, cervical cancer is the second most common form of cancer in women, which is another reason for deaths. Click the link to find all the information related the cervical cancer and also the best cancer hospitals in India

 

For better treatment opportunities for you or your loved ones, find the best blood cancer hospitals in India and the costs here.


More About: New Multiple myeloma relapse treatment

On 25th October 2022, the FDA approved a new treatment for relapsed refractory multiple Myeloma. Tecvayli (Teclistamab) got accelerated approval from the FDA. Tecvayli is approved for those who did not respond positively to four or more treatment cycles.

As per the FDA, this is the first BCMA-directed CD3 T-cell engager drug. This drug for myeloma relapse works by sticking to certain kinds of T cells that attack the cancer cells after finding them.

Click here to check the best cancer hospital in Mumbai, Delhi and Hyderabad.


The approval of Tecvayli (Teclistamab)

Teclistamab was evaluated in the study named MajesTEC-1. The study sample comprised 110 patients who had already received three prior therapies. The study's main objective was to determine the overall response rate and the percentage of patients who showed reduced symptoms of relapsed multiple myeloma. 

After the study, it was found that the overall response rate was 61.8%. In 90.6% of the patients, the positive response lasted more than six months. The positive response lasted for more than nine months in patients with excellent ORR. 

Hence Tecvayli was granted accelerated approval.


 

What are the adverse effects of Tecvayli?

There are a few side effects linked to Tecvayli, as observed among 20% of the patients who were administered Tecvayli during the Clinical study:


 

Safety information concerning Tecvayli

  • Tecvayli has a Boxed Warning for cytokine release syndrome, a disease in which the body releases an excessive amount of the inflammatory proteins known as cytokines.
  • Hepatotoxicity, infections, neutropenia, hypersensitivity, and embryo-fetal toxicity are among the warnings and precautions related to Tecvayli. 

Cancer is a life-threatening disease and a major cause of death worldwide. Its treatment is impossible to afford for the poor. Click to read through a detailed guide about free cancer treatment in India.

References:

https://pubmed.ncbi.nlm.nih.gov/35560063/

https://www.myeloma.org/treatments-subsequent-relapse

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541860/

https://www.webmd.com/cancer/multiple-myeloma/refractory-multiple-myeloma


 

Frequently Asked Questions

What is the blood cancer survival rate in India?

Is it possible to die of blood cancer?

Is it possible to totally cure blood cancer?

Is blood cancer a hereditary disease?

What effect will blood cancer treatment have on my overall quality of life?

What are the three types of cancer that affect the blood?

Relevant Blogs

Blog Banner Image

Cancer Treatment in India: Costs, Hospitals, Doctors 2024

Discover cutting-edge cancer treatment in India. Renowned specialists, advanced technology ensure comprehensive care and better outcomes. Explore options today!

Blog Banner Image

Eye Cancer Treatment in India: Advanced Care Solutions

Explore advanced eye cancer treatment in India. Renowned specialists, state-of-the-art facilities ensure comprehensive care and better outcomes. Discover options today!

Blog Banner Illustration

Organ Specific Cancer Treatment in India

Organ-specific cancer treatment in India. Explore cutting-edge therapies, compassionate care, and renewed possibilities for healing. Learn more now!

Blog Banner Image

Best Medical Tourism Companies in India 2024 List

Discover excellence in healthcare with top-rated Medical Tourism Companies in India. Your journey to world-class treatment begins here.

Blog Banner Image

PET Scan in Mumbai: Revealing Insights with Advanced Imaging

You’ll find all the available details for the PET scan in Mumbai on this page.

Blog Banner Illustration

Dr. Sandeep Nayak - Best Oncologist in Bangalore

Dr. Sandeep Nayak - Best oncologist in Bangalore. Experience of 19 years. Consults at Fortis, MACS & Ramakrishna. To book an appointment, call @ +91-98678 76979

Blog Banner Image

10 Best Hospitals in Istanbul - Updated 2023

Looking for the best hospital in Istanbul? Here is a compact list for you of the 10 Best Hospitals in Istanbul.

Blog Banner Image

15 Best Places of Hair Donation for Cancer Patients in India

Explore the best places for hair donation for cancer patients in India. Join the meaningful movement with our guide to Hair Donation for Cancer Patients in India, making a positive impact with every strand

Question and Answers

If I have a mastectomy do I need chemo?

Female | 33

That will depend on the cancer's type, how advanced it is, and if it has spread. Ask your medical team they will suggest the best treatment plan based on your specific situation.

Answered on 26th Mar '24

Dr. Donald Babu

Dr. Donald Babu

Answered on 26th Mar '24

Dr. Donald Babu

Dr. Donald Babu

My brother has liver tumor he went through surgery but doctors said there is small amount of tumor left which cant be removed through surgery.my question is will it be removed by radiation therapy/chemotherapy?

Male | 19

Radiation therapy and chemotherapy are treatment options that can help shrink liver tumors. But the effectiveness of these treatments depends on various factors such as the size and location of the remaining tumor, and the overall health of the patient. It is best to consult with an oncologist to determine the most appropriate course of treatment for your brother's condition.

Answered on 18th Mar '24

Dr. Donald Babu

Dr. Donald Babu

Cost Of Related Treatments In Country